43602-551 : Lisdexamfetamine Dimesylate 10 mg Oral Tablet, Chewable


NDC: 43602-551
Labeler: Ascent Pharmaceuticals, Inc
Product Type: Human Prescription Drug
Drug Name:  Lisdexamfetamine Dimesylate
Dosage Form: Oral Tablet, Chewable
Application #: ANDA217068
Rev. Date: 
CSA Schedule: CII (US) [1]


[1] Schedule II / IIN Controlled Substance: High potential for abuse which may lead to severe psychological or physical dependence. (i.e. Narcotics such as Dilaudid, Methadone, Demerol, Oxycodone, Percocet, Fentanyl, Morphine, Opium, Codeine, and Hydrocodone ... Schedule IIN stimulants include non-narcotic Amphetamines such as Dexedrine, Adderall, Desoxyn, Methylphenidate (Ritalin) ... Other Schedule II substances include Amobarbital, Glutethimide, and Pentobarbital. More Details: US Dept of Justice Controlled Substance Schedules.

NDC Package Codes:

  • 43602-551-05: 500 TABLET, CHEWABLE IN 1 BOTTLE (43602‑551‑05)
  • 43602-551-30: 30 TABLET, CHEWABLE IN 1 BOTTLE (43602‑551‑30)

Active Ingredients:

  • Lisdexamfetamine Dimesylate

Dosage Strength:

  • 10 mg

Pharmaceutical Classes:

  • Central Nervous System Stimulant [EPC]
  • Central Nervous System Stimulation [PE]

Related Products:

Based on records with the same trade name.
  • 43602-552 Lisdexamfetamine Dimesylate 20 mg Oral Tablet, Chewable by Ascent Pharmaceuticals, Inc
  • 43602-553 Lisdexamfetamine Dimesylate 30 mg Oral Tablet, Chewable by Ascent Pharmaceuticals, Inc
  • 43602-554 Lisdexamfetamine Dimesylate 40 mg Oral Tablet, Chewable by Ascent Pharmaceuticals, Inc
  • 43602-555 Lisdexamfetamine Dimesylate 50 mg Oral Tablet, Chewable by Ascent Pharmaceuticals, Inc
  • 43602-556 Lisdexamfetamine Dimesylate 60 mg Oral Tablet, Chewable by Ascent Pharmaceuticals, Inc
  • 43602-306 Lisdexamfetamine Dimesylate 10 mg Oral Capsule by Ascent Pharmaceuticals, Inc.
  • 43602-307 Lisdexamfetamine Dimesylate 20 mg Oral Capsule by Ascent Pharmaceuticals, Inc.
  • 43602-308 Lisdexamfetamine Dimesylate 30 mg Oral Capsule by Ascent Pharmaceuticals, Inc.
  • 43602-309 Lisdexamfetamine Dimesylate 40 mg Oral Capsule by Ascent Pharmaceuticals, Inc.
  • 43602-310 Lisdexamfetamine Dimesylate 50 mg Oral Capsule by Ascent Pharmaceuticals, Inc.
  • 43602-311 Lisdexamfetamine Dimesylate 60 mg Oral Capsule by Ascent Pharmaceuticals, Inc.
  • 43602-312 Lisdexamfetamine Dimesylate 70 mg Oral Capsule by Ascent Pharmaceuticals, Inc.
  • 0054-0370 Lisdexamfetamine Dimesylate 20 mg Oral Capsule by Hikma Pharmaceuticals USA Inc.
  • 0054-0371 Lisdexamfetamine Dimesylate 30 mg Oral Capsule by Hikma Pharmaceuticals USA Inc.
  • 0054-0372 Lisdexamfetamine Dimesylate 40 mg Oral Capsule by Hikma Pharmaceuticals USA Inc.
  • 0054-0373 Lisdexamfetamine Dimesylate 50 mg Oral Capsule by Hikma Pharmaceuticals USA Inc.
  • 0054-0374 Lisdexamfetamine Dimesylate 60 mg Oral Capsule by Hikma Pharmaceuticals USA Inc.
  • 0054-0375 Lisdexamfetamine Dimesylate 70 mg Oral Capsule by Hikma Pharmaceuticals USA Inc.
  • 0378-6854 Lisdexamfetamine Dimesylate 10 mg Oral Capsule by Mylan Pharmaceuticals Inc.
  • 0378-6855 Lisdexamfetamine Dimesylate 20 mg Oral Capsule by Mylan Pharmaceuticals Inc.
  • More related products ...

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 43602-551 QR Code

< Prev: 43602-547Next: 43602-552 >

Related Discussions:

vyvanse lisdexamfetamine 50 mg
I take a 50mg of Vyvanse at 6 am still struggling to keep a wake at 10:30 I take a second one at 2 I am still struggling... 1 reply




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.